2018
DOI: 10.1097/md.0000000000009639
|View full text |Cite
|
Sign up to set email alerts
|

Evidence supports blind screening for internal malignancy in dermatomyositis

Abstract: Supplemental Digital Content is available in the text

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
55
0
8

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 88 publications
(65 citation statements)
references
References 17 publications
2
55
0
8
Order By: Relevance
“…The association between DM and malignancy is well documented; DM can occur at the same time as, before, or after cancer diagnosis ( 3 , 4 , 16 , 17 ). The precise association between DM and malignancy is unclear, but may include the following: i) DM may occur in the setting of an immunological response to an internal malignancy; ii) there may be an increased risk of cancer in the setting of immunosuppressive therapy for DM, and iii) detection rates may be increased in the setting of heightened surveillance after either diagnosis ( 18 ). It is difficult, in most cases, to determine whether a malignancy has contributed to the development of DM or whether DM has contributed to the development of a malignant tumor.…”
Section: Discussionmentioning
confidence: 99%
“…The association between DM and malignancy is well documented; DM can occur at the same time as, before, or after cancer diagnosis ( 3 , 4 , 16 , 17 ). The precise association between DM and malignancy is unclear, but may include the following: i) DM may occur in the setting of an immunological response to an internal malignancy; ii) there may be an increased risk of cancer in the setting of immunosuppressive therapy for DM, and iii) detection rates may be increased in the setting of heightened surveillance after either diagnosis ( 18 ). It is difficult, in most cases, to determine whether a malignancy has contributed to the development of DM or whether DM has contributed to the development of a malignant tumor.…”
Section: Discussionmentioning
confidence: 99%
“…Various studies have estimated the risk of cancer in DM through various methods. A retrospective study comprising a cohort of 400 DM patients reported the development of malignancy in 15.8% of patients [ 6 ]. Other reports have placed the incidence of DM as a paraneoplastic syndrome in patients with malignancy to be between 6% and 60% [ 7 , 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hastaların %40'ı DM semptom başlangıcından 1 yıl içinde tanı almış, ileri yaş tek risk faktörü olarak saptanmıştır. Predominans bir malignite net olarak belirlenememiş olup; meme, akciğer, kolorektal, safra kesesi ve nadir görülen gastrik ve timüs maligniteleri genel popülasyonla karşılaştırılabilir dağılımda bulunmuştur (52). Bir çalışmada Non-Hodgkin lenfoma, akciğer, mesane kanser riskinde daha yüksek artış bildirilmiştir (53).…”
Section: Kanser İlişkili Miyozitunclassified